Kathleen Troeger, MPH, is the Director of Outcomes Research at Hologic, Inc., a global healthcare and diagnostics company in Marlborough, Mass. In this role, Troeger provides strategic direction for health outcomes and comparative research and clinical studies to demonstrate the value of diagnostic and surgical products to patients, providers, and policy makers. Her areas of focus include in vitro diagnostics, molecular diagnostics, cytopathology, preventive and diagnostic imaging, endocrinology, and reproductive health.
Troeger has served on several working groups of the Advanced Medical Technology Association, including the Diagnostic Value Framework Task Force, and previously held positions at Organon Pharmaceuticals and Pfizer/Parke-Davis Women’s Health Care. She is a graduate of Vassar College and received her Master of Public Health from the University of Massachusetts.
Conflict of Interest Disclosures
As of January 23, 2019
- Hologics, Inc., Employer
- Hologics, Inc., Stock
- Pfizer, Pension
- None reported